Essay On Coronary Intervention

It was established that the patient’s symptoms were due to an aortic regurgitation this was confirmed by echocardiogram. The use of the SOAPIER model is an effective means of providing rationale for a holistic clinical decision making. The findings and treatment options were discussed in a multidisciplinary meeting including Mr Jones and family. The family were informed that surgery was the safest treatment option. Complications that could happen with or without surgery were also explained ensuring that the patient had adequate understanding to make a valid choice about his treatment. Mr Jones agreed that a replacement of the aortic valve with a mechanical valve was necessary, thus it last for more than twenty years or more . Mr Jones

Aortic stenosis—aortic valve stenosis— is caused by a narrowing of the heart’s aortic valve which leads to obstruction of the outflow of the left ventricle. Aortic stenosis is uncommon in patients under the age of 50. The most common cause in adults within industrialized countries is due to aortic valve calcification. Compared to any other cardiac diseases stenosis of the aortic valve is associated with increased morbidity and mortality. Some of the more uncommon causes of this deadly disease include congenital heart disease, rheumatic fever, and radiation. Patients with increased age, increased low density lipoprotein (LDL), increased lipoprotein A, hypertension, and smoking history have a higher risk of developing a stenotic valve. Patients suffering from aortic stenosis often are asymptotic until more of the advanced symptoms develop. At this time, they may present the “classic triad symptoms,” which include (1) angina, (2) syncope, and (3) heart failure. There are also some broad symptoms such as fatigue, dyspnea (usually with exertion), swollen ankles, difficulty exercising, or palpitations. Physical examination provides valuable insight into the diagnosis of aortic stenosis. Findings on physical examination can be confirmed through non-invasive two-dimensional Doppler echocardiogram, which is the gold standard for aortic stenosis. However, other imaging modalities for diagnosis and treatment options of this debilitating disease will be discussed in this

T.S. is a 75-year-old male who has a history of coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, cerebrovascular accident, hypertension, myocardial infarction, renal failure, atrial fibrillation, dyslipidemia, and severe cervical spinal stenosis C4-5. He underwent many procedures in the past, including coronary artery bypass graft, implantation of IV dual chamber permanent pacemaker, exploratory laparotomy, and cardiac pacemaker in situ.

Personally I’ve had them all. I get my gene for my disease from my mother’s side. It isn’t a 100% accurate but my mother’s relatives are the only side that has heart issues, such as a reverse heart at berth that needed extensive heart surgery to flip it around. Every person that has aortic valve stenosis can't take medicine to cure the disease. They must have surgery, depending on how bad the back flow of blood is. In conclusion, this is my report on aortic valve

One of the patient’s secondary diagnoses is atherosclerotic heart disease of native coronary artery without angina pectoris. He had a heart valve replacement in 2011. Atherosclerosis is a disease in which plaque made of fat, cholesterol, calcium, and other substances builds up inside the arteries. This is an issue because the plaque hardens over time and narrows the arteries, which then limits the flow of oxygenated blood to vital tissues. This condition can lead to heart attacks, strokes, and death. Coronary artery atherosclerosis is the single largest killer of both men and women in the United States (Boudi, 2016). The patient’s atherosclerosis is located in the coronary artery. This artery is one of two main blood vessels that branch off

Aortic Stenosis is recognised as the most prevalent form of valvular heart disease in the ageing population. Increasing life expectancy has resulted in a significant increase in the number of older patients being referred for consideration of an aortic valve replacement. Although surgical aortic valve replacement (AVR), or open heart surgery, remains the best type of treatment for symptomatic severe aortic stenosis, other treatment options include: Transcatheter Aortic Valve Implantation (TAVI); balloon aortic valvuloplasty (BAV); medical therapy. Transcatheter Aortic Valve Implantation, also referred to as Transcatheter Aortic Valve Replacement, is one of the least invasive types of aortic valve replacement surgeries. TAVi is important to

However, in the further with further increasing numbers of SV survivors, we will probably encounter CADs in SV patients. Nevertheless and more importantly, in SV patients who have received or will receive heart transplant an previously had IMAs embolization, IMAs CABG would not be available for them when they develop transplant coronary arterial (allograft) vasculopathy. Transplant coronary arterial (allograft) vasculopathy is of the foremost causes of morbidity and mortality after heart transplantation. Surgical (CABG) and transcatheter revascularization has been reported as a successful and viable treatment options in short as well as midterm follow up [26,27]. Therefore, losing IMAs will deprive those patients from the best graft to treat their

Such contraindications could be an intolerance to long-term antiplatelet therapy or significant conditions leading to a reduced lifespan in the patient. If there is a lack of cardiac surgical support or the artery has suffered less than 50% or complete occlusion, the procedure may be voided. The patient also must not have received a bypass graft to the left anterior descending artery. (http://www.merckmanuals.com/professional/cardiovascular-disorders/cardiovascular-tests-and-procedures/percutaneous-coronary-interventions). Careful approach should be used in cases where patients suffer from diabetes and coronary artery disease or have left main disease without collateral flow and a high Syntax score. (http://emedicine.medscape.com/article/ 161446-overview).

After years of what sometimes seemed painstaking slow efforts to bring a less invasive approach to managing mitral valve (MV) disease, things are finally moving forward on several fronts. It 's likely a response to the eye-opening clinical success and rapid adoption of transcatheter aortic valve replacement (TAVR). The success of TAVR has reinvigorated efforts to develop less invasive approaches to the other heart valves. It has not been easy, but the transcatheter revolution marches on.

My clinical observation took place at Christus Trinity Mother Frances Hospital in Tyler, Texas involving a mini mitral valve replacement procedure. This location is not a teaching institution, therefore there are no clinical instructors nor students. The acting perfusionist in the procedure was Darell Miller under the direction of cardiothoracic surgeon Neeland Doolabh M.D.

This is to certify that Mr. Esmaeil Farshi, date of birth 09/06/1967, is under treatment because of heart disease at UC San Diego Sulpizio Cardiovascular Center starting February 15, 2017. This patient has been diagnosed with heart vascular disease. Therefore, a surgery has been scheduled for him on Monday February 20. Mr. Farshi will stay at this hospital about two

7 Calcific aortic valve stenosis is the most common valvular pathology requiring valve replacement and showing some evidence of aortic valve thickening known as valvular sclerosis.

Writing in JACC: Cardiovascular Interventions, Aboulhosn et al report that the longevity of surgical repair, with an annuloplasty ring, of tricuspid regurgitation “remains suboptimal”—commenting that “more than 25% of patients” develop progressive moderate or severe tricuspid regurgitation within five years or repair “depending on various clinical and technical factors”. They add that patients with failing annuloplasty rings are often complex and have numerous comorbidities, making them “at high risk for adverse outcomes” after tricuspid valve reoperation. For this reason, the authors note, off-label transcatheter valve-in-ring procedures are an “appealing alternative” to re-do surgery. Therefore, given “little is known” about the results of transcatheter valve-in-ring procedures, Aboulhosn et al reviewed data collected from a registry of institutions that have performed such procedures.

An estimated 200,000 aortic valve replacements are done yearly. Surgical valve replacements frequently use BP valves over mechanical valves. 2 All transcatheter valves are bioprosthetic (BP) and have been increasingly used in patients with severe aortic stenosis deemed to be at high surgical risk. 13 TAVR was

_____(Central) aortic valve replacement for aortic valve stenosis, it is almost like subvalvular membranous tunnel-like stenosis.